共 232 条
[11]
Cannegieter SC(2008)Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement J Clin Endocrinol Metab 93 2454-2462
[12]
Ehrenstein V(2014)Medical management of Cushing’s disease J Neurooncol 117 407-414
[13]
Vandenbroucke JP(2012)Body composition and cardiovascular risk markers after remission of Cushing’s disease: a prospective study using whole-body MRI J Clin Endocrinol Metab 97 1702-1711
[14]
Pereira AM(2013)Persistence of Cushing’s disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation Endocr Pract 19 252-258
[15]
Sorensen HT(2009)Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome J Clin Endocrinol Metab 94 3365-3371
[16]
Clayton RN(2001)Incidence and late prognosis of Cushing’s syndrome: a population-based study J Clin Endocrinol Metab 86 117-123
[17]
Raskauskiene D(2015)Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 100 2807-2831
[18]
Reulen RC(2005)Long-term remission rates after pituitary surgery for Cushing’s disease: the need for long-term surveillance Clin Endocrinol 63 549-559
[19]
Jones PW(2014)Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing’s disease: care reality in the Munich Metropolitan Region Eur J Endocrinol 170 283-292
[20]
Ntali G(2012)Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years J Clin Endocrinol Metab 97 1194-1201